HMGA2 and pancreatic ductal adenocarcinoma: Patients with high expressed HMGA2 in ccRCC, head and neck cancer, hepatocellular carcinoma and pancreatic ductal adenocarcinoma showed a significant shorter OS than patients with a low level of HMGA2 expression.